Meet Facebook's new neighbor: Cutting-edge cell therapy company lands big East Bay space

In a race to develop so-called allogeneic cell therapies — designed to treat dozens of patients with one manufacturing batch made from cells of healthy donors — the company landed a 118,000-square-foot lease in Newark.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.